NCT01161160View on ClinicalTrials.gov

Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old

PHASE2CompletedINTERVENTIONAL
Enrollment

209

Participants

Timeline

Start Date

July 1, 2010

Primary Completion Date

August 23, 2010

Study Completion Date

January 31, 2011

Conditions
Influenza
Interventions
BIOLOGICAL

GSK Biologicals' GSK2340274A (two different formulations)

Intramuscular injection

BIOLOGICAL

GSK Biologicals' - GSK2340272A

Intramuscular injection

Trial Locations (2)

1008

GSK Investigational Site, Sampaloc, Manila

10400

GSK Investigational Site, Bangkok

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01161160 - Safety and Immune Response of Candidate H1N1 Influenza Vaccines GSK2340274A and GSK234072A in Children 3 to Less Than 10 Years Old | Biotech Hunter | Biotech Hunter